HomeKRON • NASDAQ
add
Kronos Bio Inc
Previous close
$0.85
Day range
$0.80 - $0.90
Year range
$0.69 - $1.59
Market cap
51.20M USD
Avg Volume
82.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 2.69M | 44.21% |
Operating expense | 20.13M | -35.30% |
Net income | -16.20M | 45.53% |
Net profit margin | -602.68 | 62.23% |
Earnings per share | — | — |
EBITDA | -17.02M | 40.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 136.65M | -37.74% |
Total assets | 164.27M | -36.97% |
Total liabilities | 41.13M | -28.19% |
Total equity | 123.15M | — |
Shares outstanding | 60.29M | — |
Price to book | 0.42 | — |
Return on assets | -25.12% | — |
Return on capital | -27.71% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -16.20M | 45.53% |
Cash from operations | -16.33M | 34.75% |
Cash from investing | 40.18M | 647.60% |
Cash from financing | 164.00K | -56.38% |
Net change in cash | 24.01M | 224.57% |
Free cash flow | -9.44M | 28.04% |
About
Founded
2017
Headquarters
Website
Employees
58
